InvestorsHub Logo
Post# of 251837
Next 10
Followers 829
Posts 119653
Boards Moderated 16
Alias Born 09/05/2002

Re: DewDiligence post# 217991

Thursday, 09/20/2018 11:41:07 AM

Thursday, September 20, 2018 11:41:07 AM

Post# of 251837
OMED -13% on CELG’s declining option to license Navicixizumab:

https://finance.yahoo.com/news/oncomed-provides-navicixizumab-partnership-120000730.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.